Moreover, NSCLC patients with uncommon EGFR mutation, including G719X, L861Q, S768I, and Ex20 ins, had more abundant PD-L1 expression accompanied by CD8+ tumor-infiltrating lymphocytes(TILs) infiltration (37). Here, EGFR is linked to non-small cell lung carcinoma.